, Volume 18, Issue 4, pp 441–447 | Cite as

Autoimmune lymphocytic hypophysitis in association with autoimmune eye disease and sequential treatment with infliximab and rituximab

  • Chengyu Xu
  • Adriana Ricciuti
  • Patrizio Caturegli
  • C. Dirk Keene
  • Atil Y. Kargi



Autoimmune lymphocytic hypophysitis associates predominantly with other autoimmune endocrinopathies and is most commonly treated with glucocorticoids and/or decompressive pituitary surgery. Here we report a new association and treatment modality for lymphocytic hypophysitis.


A 52-year-old woman presented with scleritis, uveitis, facial palsy, and central diabetes insipidus, accompanied by thickened pituitary stalk and enlarged pituitary on cranial MRI. Neurosarcoidosis was suspected and treatment with glucocorticoids and methotrexate initiated. Since symptoms persisted, infliximab (a monoclonal antibody that antagonizes tumor necrosis factor alpha) was added to her regimen. The patient initially improved but after 6 months developed recurrent pituitary enlargement, bilateral optic neuritis, and panhypopituitarism. To ascertain the nature of the pituitary lesion, she underwent transsphenoidal biopsy, which revealed lymphocytic hypophysitis with numerous CD20 positive B lymphocytes. The pathological finding suggested to us that administration of rituximab (a monoclonal antibody that lyzes B cells expressing CD20) could be useful. Following two courses of rituximab, the pituitary mass resolved and the corticotroph axis partially recovered. The patient has remained in remission during 3 years of follow up.


This is the first report of hypophysitis occurring with the triad of scleritis, uveitis, and optic neuritis, as well as the first immunotherapy based on the sequential use of infliximab and rituximab.


Lymphocytic hypophysitis Optic neuritis Scleritis Uveitis Immunotherapy Rituximab Infliximab 


Conflict of interest

The authors have nothing to disclose.

Supplementary material

11102_2014_592_MOESM1_ESM.docx (17 kb)
Supplementary material 1 (DOCX 16 kb)


  1. 1.
    Leporati P, Landek-Salgado MA, Lupi I, Chiovato L, Caturegli P (2011) IgG4-related hypophysitis: a new addition to the hypophysitis spectrum. J Clin Endocrinol Metab 96(7):1971–1980PubMedCentralPubMedCrossRefGoogle Scholar
  2. 2.
    Gutenberg A, Landek-Salgado MA, Tzou SC, Lupi I, Geis A, Kimura H, Caturegli P (2009) Autoimmune hypophysitis: expanding the differential diagnosis to CTLA-4 blockade. Expert Rev Endocrinol Metab 4:681–698CrossRefGoogle Scholar
  3. 3.
    Culver ME, Gatesman ML, Mancl EE, Lowe DK (2011) Ipilimumab: a novel treatment for metastatic melanoma. Ann Pharmacother 45:510–519PubMedCrossRefGoogle Scholar
  4. 4.
    Blank CU (2014) The perspective of immunotherapy: new molecules and new mechanisms of action in immune modulation. Curr Opin Oncol 26(2):204–214PubMedCrossRefGoogle Scholar
  5. 5.
    Caturegli P, Iwama S (2013) From Japan with love: another tessera in the hypophysitis mosaic. J Clin Endocrinol Metab 98:1865–1868PubMedCrossRefGoogle Scholar
  6. 6.
    Iuliano SL, Laws ER (2011) The diagnosis and management of lymphocytic hypophysitis. Expert Rev Endocrinol Metab 6:777–783CrossRefGoogle Scholar
  7. 7.
    Iseda I, Hida K, Tone A, Tenta M, Shibata Y, Matsuo K, Yamadori I, Hashimoto K (2014) Prednisolone markedly reduced serum IgG4 levels along with the improvement of pituitary mass and anterior pituitary function in a patient with IgG4-related infundibulo-hypophysitis. Endocr J 61(2):195–203PubMedCrossRefGoogle Scholar
  8. 8.
    Caturegli P, Newschaffer C, Olivi A, Pomper MG, Burger PC, Rose NR (2005) Autoimmune hypophysitis. Endocr Rev 26:599–614PubMedCrossRefGoogle Scholar
  9. 9.
    Goudie RB, Pinkerton PH (1962) Anterior hypophysitis and Hashimoto’s disease in a woman. J Pathol Bacteriol 83:584–585PubMedCrossRefGoogle Scholar
  10. 10.
    Beressi N, Beressi JP, Cohen R, Modigliani E (1999) Lymphocytic hypophysitis. A review of 145 cases. Ann Med Interne (Paris) 150:327–341Google Scholar
  11. 11.
    Tzou SC, Lupi I, Landek-Salgado MA, Gutenberg A, Tzou YM, Kimura H, Pinna G, Rose NR, Caturegli P (2008) Autoimmune hypophysitis of SJL mice: clinical insights from a new animal model. Endocrinology 149(7):3461–3469PubMedCentralPubMedCrossRefGoogle Scholar
  12. 12.
    Gutenberg A, Larsen J, Lupi I, Rohde V, Caturegli P (2009) A radiologic score to distinguish autoimmune hypophysitis from nonsecreting pituitary adenoma preoperatively. AJNR Am J Neuroradiol 30:1–8CrossRefGoogle Scholar
  13. 13.
    Nakata Y, Sato N, Masumoto T, Mori H, Akai H, Nobusawa H, Adachi Y, Oba H, Ohtomo K (2010) Parasellar T2 dark sign on MR imaging in patients with lymphocytic hypophysitis. AJNR Am J Neuroradiol 31:1944–1950PubMedCrossRefGoogle Scholar
  14. 14.
    Al-Mujaini A, Ganesh A, Al-Zuhaibi S, Al-Dhuhli H, Al-Mashani A, Al-Kindi H, Al-Memari A, Al-Futaisi A, Al-Asmi A (2009) Lymphocytic infundibulo-neurohypophysitis: an unusual cause of recurrent optic neuropathy in a child. J Aapos 13:207–209PubMedCrossRefGoogle Scholar
  15. 15.
    Bianchi A, Mormando M, Doglietto F, Tartaglione L, Piacentini S, Lauriola L, Maira G, De Marinis L (2013) Hypothalamitis: a diagnostic and therapeutic challenge. Pituitary 17(3):197–202CrossRefGoogle Scholar
  16. 16.
    Ouma JR, Farrell VJ (2002) Lymphocytic infundibulo- neurohypophysitis with hypothalamic and optic pathway involvement: report of a case and review of the literature. Surg Neurol 57:49–53; discussion 53–44Google Scholar
  17. 17.
    Schreckinger M, Francis T, Rajah G, Jagannathan J, Guthikonda M, Mittal S (2012) Novel strategy to treat a case of recurrent lymphocytic hypophysitis using rituximab. J Neurosurg 116:1318–1323PubMedCrossRefGoogle Scholar
  18. 18.
    Zoeller GK, Benveniste RJ, Farhadi FA, Bruce JH (2010) Lymphocytic hypophysitis in a patient presenting with sequential episodes of optic neuritis. Pituitary 15(1):101–105CrossRefGoogle Scholar
  19. 19.
    Hashimoto M, Otsuka K, Imaizumi H, Wada H (1998) A case of presumed lymphocytic adenohypophysitis. Atarashi ganka 15:751–753Google Scholar
  20. 20.
    Ogasawara M, Shikishima K, Sakai T, Osada M, Tanaka K (2012) Two cases of optic neuritis with hypophysitis. 29:189–195Google Scholar
  21. 21.
    Saito S, Mori C, Toma K, Kubori T, Nishinaka K, Udaka F (2011) A case of optic neuritis associated with lymphocytic hypophysitis revealed by pattern-reversal VEP. Rinsho Shinkeigaku 51:27–31PubMedCrossRefGoogle Scholar
  22. 22.
    Shimmyo A, Izaki A (1997) Lymphocytic adenohypophysitis with total ophthalmoplegia. Nihon Shinkei Ganka Gakkai 14:38–43Google Scholar
  23. 23.
    Tamiya A, Saeki N, Mizota A (2001) Lymphocytic infundibulo-neurohypophysitis associated with recurrent optic neuritis. Br J Neurosurg 15:180–183PubMedCrossRefGoogle Scholar
  24. 24.
    Uemura A, Mizota A, Usami-Adachi E, Saeki N (2001) Follow-up studies of optic neuritis with lymphocytic adenohypophysitis. Nippon Ganka Gakkai Zasshi 105:535–538PubMedGoogle Scholar
  25. 25.
    Arsava EM, Uluc K, Kansu T, Dogulu CF, Soylemezoglu F, Selekler K (2001) Granulomatous hypophysitis and bilateral optic neuropathy. J Neuroophthalmol 21:34–36PubMedCrossRefGoogle Scholar
  26. 26.
    Jin-No M, Fujii T, Jin-No Y, Kamiya Y, Okada M, Kawaguchi M (1999) Central diabetes insipidus with Behcet’s disease. Intern Med 38:995–999PubMedCrossRefGoogle Scholar
  27. 27.
    Taji K, Takamura T, Mouri K, Kawamo M, Akahori H, Ishikura K, Takeshita Y, Misu H, Hayashi Y, Hamada J, Kaneko S (2009) A male case of lymphocytic hypophysitis occurred during the course of IgG4-related disease. Jpn J Endocrinol 85:42–44Google Scholar
  28. 28.
    Lupi I, Manetti L, Raffaelli V, Lombardi M, Cosottini M, Iannelli A, Basolo F, Proietti A, Bogazzi F, Caturegli P, Martino E (2011) Diagnosis and treatment of autoimmune hypophysitis: a short review. J Endocrinol Invest 34:e245–e252PubMedGoogle Scholar
  29. 29.
    Thodou E, Asa SL, Kontogeorgos G, Kovacs K, Horvath E, Ezzat S (1995) Lymphocytic hypophysitis: clinicopathological findings. J Clin Endocrinol Metab 80:2302–2311PubMedGoogle Scholar
  30. 30.
    Kristof RA, Van Roost D, Klingmuller D, Springer W, Schramm J (1999) Lymphocytic hypophysitis: non-invasive diagnosis and treatment by high dose methylprednisolone pulse therapy? J Neurol Neurosurg Psychiatry 67:398–402PubMedCentralPubMedCrossRefGoogle Scholar
  31. 31.
    Smolen JS, Emery P (2011) Infliximab: 12 years of experience. Arthritis Res Ther 13(Suppl 1):S2PubMedCentralPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Chengyu Xu
    • 1
  • Adriana Ricciuti
    • 2
  • Patrizio Caturegli
    • 2
  • C. Dirk Keene
    • 3
  • Atil Y. Kargi
    • 1
  1. 1.Division of Endocrinology, Diabetes and Metabolism, Department of MedicineUniversity of Miami Miller School of MedicineMiamiUSA
  2. 2.Department of PathologyThe Johns Hopkins University School of MedicineBaltimoreUSA
  3. 3.Department of PathologyUniversity of Washington School of MedicineSeattleUSA

Personalised recommendations